Eur J Endocrinol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


DOI: 10.1530/eje.0.1300327
European Journal of Endocrinology, Vol 130, Issue 4, 327-332
Copyright © 1994 by European Society of Endocrinology
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lumbroso, S.
Right arrow Articles by Sultan, C.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Lumbroso, S.
Right arrow Articles by Sultan, C.

RESEARCH-ARTICLE

Molecular prenatal exclusion of familial partial androgen insensitivity (Reifenstein syndrome)

Serge Lumbroso, Jean-Marc Lobaccaro, Charles Belon, Serge Amram, Bruno Bachelard, Patrick Garandeau and Charles Sultan

Lumbroso S, Lobaccaro J-M, Belon C, Amram S, Bachelard B, Garandeau P, Sultan C. Molecular prenatal exclusion of familial partial androgen insensitivity (Reifenstein syndrome). Eur J Endocrinol 1994;130:327–32. ISSN 0804–4643

In a large family with Reifenstein syndrome, we previously performed molecular analysis of the androgen receptor gene. Direct sequencing showed a G–A point mutation at position 2818 of exon 7, which was responsible for an arginine–histidine substitution at position 840 of the androgen receptor. In this family, the proband's mother became pregnant and wished to know whether she was carrying an unaffected fetus. Polymerase chain reactions of the sex-determining region of the Y chromosome (the SRY gene) on trophoblastic DNA at week 14 revealed a 46,XY genotype. Sequencing analysis showed the canonical sequence (CGT, encoding an Arg residue), suggesting that the fetus was not affected. The expectation of normal male sexual development was confirmed by detection of normal male external genitalia through ultrasonography at week 24. These data confirm that sequence analysis of the androgen receptor gene on trophoblastic DNA is the most reliable method for prenatally diagnosing or excluding androgen insensitivity syndrome in high-risk families.

Charles Sultan, Endocrinologie et Gynécologie Pédiatriques, Service de Pédiatrie I, Hôpital A. de Villeneuve, 34059 Montpellier Cedex, France




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
M. Behr, D. B. Ramsden, and U. Loos
Deoxyribonucleic Acid Binding and Transcriptional Silencing by a Truncated c-erbA{beta}1 Thyroid Hormone Receptor Identified in a Severely Retarded Patient with Resistance to Thyroid Hormone
J. Clin. Endocrinol. Metab., April 1, 1997; 82(4): 1081 - 1087.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1994 European Society of Endocrinology.